{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:33:40Z","timestamp":1787240020739,"version":"build-2736575974"},"reference-count":152,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s13311-023-01348-6","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T13:04:07Z","timestamp":1676293447000},"page":"140-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations"],"prefix":"10.1016","volume":"20","author":[{"given":"Shreya N.","family":"Kashyap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1810-9763","authenticated-orcid":false,"given":"Erik D.","family":"Roberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-023-01348-6_bib1","doi-asserted-by":"crossref","first-page":"34873","DOI":"10.1074\/jbc.M405131200","article-title":"Promotion of hyperphosphorylation by frontotemporal dementia tau mutations","volume":"279","author":"Alonso","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-023-01348-6_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01348-6_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","article-title":"Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01348-6_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00401-013-1238-y","article-title":"Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)","volume":"127","author":"Brettschneider","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01348-6_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-007-0223-8","article-title":"The neuropathology and clinical phenotype of FTD with progranulin mutations","volume":"114","author":"Mackenzie","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01348-6_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/nen.0b013e31803020b9","article-title":"TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations","volume":"66","author":"Neumann","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00401-006-0138-9","article-title":"Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype","volume":"112","author":"Mackenzie","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01348-6_bib8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/acn3.50802","article-title":"Neuroinflammation in frontotemporal lobar degeneration revealed by (11) C-PBR28 PET","volume":"6","author":"Kim","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2009.03.024","article-title":"Neurodegenerative diseases target large-scale human brain networks","volume":"62","author":"Seeley","year":"2009","journal-title":"Neuron"},{"key":"10.1007\/s13311-023-01348-6_bib10","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1212\/WNL.0000000000000583","article-title":"Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia","volume":"83","author":"Dopper","year":"2014","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01348-6_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/cercor\/bhr004","article-title":"Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia","volume":"22","author":"Kim","year":"2012","journal-title":"Cereb Cortex"},{"key":"10.1007\/s13311-023-01348-6_bib12","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/brain\/awq075","article-title":"Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease","volume":"133","author":"Zhou","year":"2010","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01348-6_bib13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","article-title":"Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes","volume":"86","author":"Coyle-Gilchrist","year":"2016","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01348-6_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12031-011-9538-y","article-title":"Estimating the number of persons with frontotemporal lobar degeneration in the US population","volume":"45","author":"Knopman","year":"2011","journal-title":"J Mol Neurosci"},{"key":"10.1007\/s13311-023-01348-6_bib15","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/WNL.58.11.1615","article-title":"The prevalence of frontotemporal dementia","volume":"58","author":"Ratnavalli","year":"2002","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01348-6_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jnnp.2009.195719","article-title":"Survival in progressive supranuclear palsy and frontotemporal dementia","volume":"81","author":"Chiu","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-023-01348-6_bib17","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1212\/01.WNL.0000158425.46019.5C","article-title":"The natural history of temporal variant frontotemporal dementia","volume":"64","author":"Seeley","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01348-6_bib18","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/brain\/awg204","article-title":"Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study","volume":"126","author":"Rosso","year":"2003","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01348-6_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/09540261.2013.776523","article-title":"The epidemiology of frontotemporal dementia","volume":"25","author":"Onyike","year":"2013","journal-title":"Int Rev Psychiatry"},{"key":"10.1007\/s13311-023-01348-6_bib20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/01.wnl.0000173837.82820.9f","article-title":"Frontotemporal dementia progresses to death faster than Alzheimer disease","volume":"65","author":"Roberson","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01348-6_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1176\/appi.focus.20160018","article-title":"A clinical guide to frontotemporal dementias","volume":"14","author":"Ljubenkov","year":"2016","journal-title":"Focus"},{"key":"10.1007\/s13311-023-01348-6_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0034-1381735","article-title":"Frontotemporal lobar degeneration: a clinical approach","volume":"34","author":"Karageorgiou","year":"2014","journal-title":"Semin Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib23","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/WAD.0b013e31815c3445","article-title":"Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions","volume":"21","author":"Rascovsky","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1007\/s13311-023-01348-6_bib24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1474-4422(07)70266-1","article-title":"Semantic dementia: a unique clinicopathological syndrome","volume":"6","author":"Hodges","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib25","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00415-009-5073-y","article-title":"The underlying mechanisms of verbal fluency deficit in frontotemporal dementia and semantic dementia","volume":"256","author":"Laisney","year":"2009","journal-title":"J Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/1531-8249(200001)47:1<36::AID-ANA8>3.0.CO;2-L","article-title":"A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory","volume":"47","author":"Mummery","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/WNL.0000000000000031","article-title":"In vivo signatures of nonfluent\/agrammatic primary progressive aphasia caused by FTLD pathology","volume":"82","author":"Caso","year":"2014","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01348-6_bib28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01348-6_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrneurol.2009.216","article-title":"Primary progressive aphasia: clinicopathological correlations","volume":"6","author":"Grossman","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.729381","article-title":"The psychiatric misdiagnosis of behavioral variant frontotemporal dementia in a Colombian sample","volume":"12","author":"Zapata-Restrepo","year":"2021","journal-title":"Front Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib31","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1212\/WNL.0000000000004614","article-title":"The social and economic burden of frontotemporal degeneration","volume":"89","author":"Galvin","year":"2017","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01348-6_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11940-014-0319-0","article-title":"Treatment of frontotemporal dementia","volume":"16","author":"Tsai","year":"2014","journal-title":"Curr Treat Options Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/alz.12001","article-title":"Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration","volume":"16","author":"Casaletto","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-023-01348-6_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11910-006-0050-7","article-title":"Frontotemporal dementia","volume":"6","author":"Roberson","year":"2006","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1007\/s13311-023-01348-6_bib35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archneur.56.7.817","article-title":"Inheritance of frontotemporal dementia","volume":"56","author":"Chow","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib36","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves","year":"2019","journal-title":"J Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1750-3639.2007.00052.x","article-title":"Hereditary frontotemporal dementia caused by tau gene mutations","volume":"17","author":"van Swieten","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1007\/s13311-023-01348-6_bib38","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/hmg\/ddi182","article-title":"Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region","volume":"14","author":"Cruts","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-023-01348-6_bib39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-013-1149-y","article-title":"Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons","volume":"126","author":"Almeida","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01348-6_bib40","doi-asserted-by":"crossref","first-page":"e56899","DOI":"10.1371\/journal.pone.0056899","article-title":"C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients","volume":"8","author":"Dobson-Stone","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-023-01348-6_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1007\/s13311-023-01348-6_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jamaneurol.2013.6002","article-title":"Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile","volume":"71","author":"Devenney","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/humu.20651","article-title":"Progranulin locus deletion in frontotemporal dementia","volume":"29","author":"Gijselinck","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1007\/s13311-023-01348-6_bib44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/humu.20681","article-title":"Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia","volume":"29","author":"Mukherjee","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1007\/s13311-023-01348-6_bib45","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nature05017","article-title":"Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21","volume":"442","author":"Cruts","year":"2006","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01348-6_bib46","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1093\/hmg\/ddl241","article-title":"Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration","volume":"15","author":"Gass","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-023-01348-6_bib47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/humu.20520","article-title":"Progranulin null mutations in both sporadic and familial frontotemporal dementia","volume":"28","author":"Le Ber","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1007\/s13311-023-01348-6_bib48","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1074\/jbc.M705115200","article-title":"Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion","volume":"283","author":"Shankaran","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-023-01348-6_bib49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.ejhg.5201772","article-title":"Progranulin mutations in Dutch familial frontotemporal lobar degeneration","volume":"15","author":"Bronner","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s13311-023-01348-6_bib50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12883-017-0959-2","article-title":"A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review","volume":"17","author":"Hosaka","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib51","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1471-4159.2009.06546.x","article-title":"Pathogenic cysteine mutations affect progranulin function and production of mature granulins","volume":"112","author":"Wang","year":"2010","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-023-01348-6_bib52","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/mds.29144","article-title":"GRN Mutations are Associated with Lewy body dementia","volume":"37","author":"Reho","year":"2022","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01348-6_bib53","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/2013.jamaneurol.393","article-title":"Progranulin mutations as risk factors for Alzheimer disease","volume":"70","author":"Perry","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40478-021-01250-2","article-title":"Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study","volume":"9","author":"Dugan","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01348-6_bib55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","article-title":"Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis","volume":"18","author":"Mole","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11910-013-0366-z","article-title":"Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum","volume":"13","author":"Cotman","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1007\/s13311-023-01348-6_bib57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/eye.1998.148","article-title":"The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses","volume":"12","author":"Weleber","year":"1998","journal-title":"Eye"},{"key":"10.1007\/s13311-023-01348-6_bib58","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s13311-023-01348-6_bib59","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.braindev.2019.03.004","article-title":"Neuronal ceroid lipofuscinosis type-11 in an adolescent","volume":"41","author":"Kamate","year":"2019","journal-title":"Brain Dev"},{"key":"10.1007\/s13311-023-01348-6_bib60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/brain\/awz377","article-title":"Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms","volume":"143","author":"Huin","year":"2020","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01348-6_bib61","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1007\/s13311-023-01348-6_bib62","first-page":"82","article-title":"Management of Gaucher disease: enzyme replacement therapy","volume":"12","author":"Zimran","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1007\/s13311-023-01348-6_bib63","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1590\/S1415-47572012000600009","article-title":"Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis","volume":"35","author":"Alegra","year":"2012","journal-title":"Genet Mol Biol"},{"key":"10.1007\/s13311-023-01348-6_bib64","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12032-017-1054-7","article-title":"Progranulin and its biological effects in cancer","volume":"34","author":"Arechavaleta-Velasco","year":"2017","journal-title":"Med Oncol"},{"key":"10.1007\/s13311-023-01348-6_bib65","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.21037\/tcr-20-2972","article-title":"A narrative review of multiple mechanisms of progranulin in cancer: a potential target for anti-cancer therapy","volume":"10","author":"Zhou","year":"2021","journal-title":"Transl Cancer Res"},{"key":"10.1007\/s13311-023-01348-6_bib66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4137\/BCBCR.S7224","article-title":"Increased circulating level of the survival factor GP88 (progranulin) in the serum of breast cancer patients when compared to healthy subjects","volume":"5","author":"Tkaczuk","year":"2011","journal-title":"Breast Cancer (Auckl)"},{"key":"10.1007\/s13311-023-01348-6_bib67","doi-asserted-by":"crossref","first-page":"e39880","DOI":"10.1371\/journal.pone.0039880","article-title":"Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study","volume":"7","author":"Koo","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-023-01348-6_bib68","doi-asserted-by":"crossref","first-page":"39980","DOI":"10.18632\/oncotarget.9556","article-title":"Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin","volume":"7","author":"Buraschi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1007\/s13311-023-01348-6_bib69","doi-asserted-by":"crossref","first-page":"14202","DOI":"10.1073\/pnas.95.24.14202","article-title":"Inhibition of tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin\/granulin precursor)","volume":"95","author":"Zhang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01348-6_bib70","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1158\/1535-7163.MCT-14-0012","article-title":"Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agents","volume":"13","author":"Wong","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1007\/s13311-023-01348-6_bib71","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/onc.2014.92","article-title":"Progranulin promotes temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness","volume":"34","author":"Bandey","year":"2015","journal-title":"Oncogene"},{"key":"10.1007\/s13311-023-01348-6_bib72","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1110\/ps.073295308","article-title":"Structure dissection of human progranulin identifies well-folded granulin\/epithelin modules with unique functional activities","volume":"17","author":"Tolkatchev","year":"2008","journal-title":"Protein Sci"},{"key":"10.1007\/s13311-023-01348-6_bib73","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0100-17.2017","article-title":"Intracellular proteolysis of progranulin generates stable, lysosomal granulins that are haploinsufficient in patients with frontotemporal dementia caused by GRN mutations","volume":"4","author":"Holler","year":"2017","journal-title":"eNeuro"},{"key":"10.1007\/s13311-023-01348-6_bib74","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0092-8674(88)80026-6","article-title":"The mannose 6-phosphate receptor and the biogenesis of lysosomes","volume":"52","author":"Griffiths","year":"1988","journal-title":"Cell"},{"key":"10.1007\/s13311-023-01348-6_bib75","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuron.2010.09.034","article-title":"Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin","volume":"68","author":"Hu","year":"2010","journal-title":"Neuron"},{"key":"10.1007\/s13311-023-01348-6_bib76","doi-asserted-by":"crossref","first-page":"e21023","DOI":"10.1371\/journal.pone.0021023","article-title":"C-terminus of progranulin interacts with the beta-propeller region of sortilin to regulate progranulin trafficking","volume":"6","author":"Zheng","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-023-01348-6_bib77","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/hmg\/ddz229","article-title":"Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity","volume":"29","author":"Valdez","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-023-01348-6_bib78","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1083\/jcb.201502029","article-title":"Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin","volume":"210","author":"Zhou","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1007\/s13311-023-01348-6_bib79","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.celrep.2017.08.056","article-title":"Lipidomic and transcriptomic basis of lysosomal dysfunction in progranulin deficiency","volume":"20","author":"Evers","year":"2017","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-023-01348-6_bib80","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/glia.23547","article-title":"Dedifferentiated Schwann cells secrete progranulin that enhances the survival and axon growth of motor neurons","volume":"67","author":"Hyung","year":"2019","journal-title":"Glia"},{"key":"10.1007\/s13311-023-01348-6_bib81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2202-10-130","article-title":"Progranulin is expressed within motor neurons and promotes neuronal cell survival","volume":"10","author":"Ryan","year":"2009","journal-title":"BMC Neurosci"},{"key":"10.1007\/s13311-023-01348-6_bib82","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1523\/JNEUROSCI.6244-10.2011","article-title":"Progranulin deficiency decreases gross neural connectivity but enhances transmission at individual synapses","volume":"31","author":"Tapia","year":"2011","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01348-6_bib83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20091568","article-title":"Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice","volume":"207","author":"Yin","year":"2010","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-023-01348-6_bib84","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1093\/hmg\/ddx364","article-title":"Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients","volume":"26","author":"Valdez","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-023-01348-6_bib85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-017-1719-5","article-title":"Regulation of cathepsin D activity by the FTLD protein progranulin","volume":"134","author":"Zhou","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01348-6_bib86","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s40478-019-0872-6","article-title":"Impaired beta-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations","volume":"7","author":"Arrant","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01348-6_bib87","doi-asserted-by":"crossref","first-page":"e0212382","DOI":"10.1371\/journal.pone.0212382","article-title":"Progranulin deficiency leads to reduced glucocerebrosidase activity","volume":"14","author":"Zhou","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-023-01348-6_bib88","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","article-title":"Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis","volume":"38","author":"Arrant","year":"2018","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01348-6_bib89","doi-asserted-by":"crossref","first-page":"100993","DOI":"10.1016\/j.jbc.2021.100993","article-title":"Delivering progranulin to neuronal lysosomes protects against excitotoxicity","volume":"297","author":"Davis","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-023-01348-6_bib90","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41398-022-01875-4","article-title":"Progranulin improves neural development via the PI3K\/Akt\/GSK-3\u03b2 pathway in the cerebellum of a VPA-induced rat model of ASD","volume":"12","author":"Wang","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1007\/s13311-023-01348-6_bib91","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.nbd.2011.10.016","article-title":"Synaptic dysfunction in progranulin-deficient mice","volume":"45","author":"Petkau","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01348-6_bib92","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/hmg\/ddx162","article-title":"Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo","volume":"26","author":"Beel","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-023-01348-6_bib93","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1124\/jpet.117.242164","article-title":"Depletion of progranulin reduces GluN2B-containing NMDA receptor density, tau phosphorylation, and dendritic arborization in mouse primary cortical neurons","volume":"363","author":"Longhena","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-023-01348-6_bib94","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1002\/cne.22430","article-title":"Progranulin expression in the developing and adult murine brain","volume":"518","author":"Petkau","year":"2010","journal-title":"J Comp Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib95","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.nbd.2018.11.011","article-title":"Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice","volume":"124","author":"Arrant","year":"2018","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01348-6_bib96","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nbd.2017.06.012","article-title":"Conditional loss of progranulin in neurons is not sufficient to cause neuronal ceroid lipofuscinosis-like neuropathology in mice","volume":"106","author":"Petkau","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01348-6_bib97","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136147","article-title":"Microglia regulate brain progranulin levels through the endocytosis\/lysosomal pathway","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"key":"10.1007\/s13311-023-01348-6_bib98","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12974-017-1000-9","article-title":"Selective depletion of microglial progranulin in mice is not sufficient to cause neuronal ceroid lipofuscinosis or neuroinflammation","volume":"14","author":"Petkau","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1007\/s13311-023-01348-6_bib99","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ajpath.2010.11.002","article-title":"Progranulin is a chemoattractant for microglia and stimulates their endocytic activity","volume":"178","author":"Pickford","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1007\/s13311-023-01348-6_bib100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2011.08.029","article-title":"Core features of frontotemporal dementia recapitulated in progranulin knockout mice","volume":"45","author":"Ghoshal","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01348-6_bib101","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","article-title":"Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation","volume":"165","author":"Lui","year":"2016","journal-title":"Cell"},{"key":"10.1007\/s13311-023-01348-6_bib102","first-page":"97","article-title":"The role of progranulin (PGRN) in the modulation of anti-inflammatory response in asthma","volume":"44","author":"Pogonowska","year":"2019","journal-title":"Cent Eur J Immunol"},{"key":"10.1007\/s13311-023-01348-6_bib103","volume":"2015","author":"Andr\u00e9s Cerezo","year":"2015","journal-title":"Progranulin is associated with disease activity in patients with rheumatoid arthritis. Mediators Inflamm"},{"key":"10.1007\/s13311-023-01348-6_bib104","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00335-019-09798-0","article-title":"Model validity for preclinical studies in precision medicine: precisely how precise do we need to be?","volume":"30","author":"Tadenev","year":"2019","journal-title":"Mamm Genome"},{"key":"10.1007\/s13311-023-01348-6_bib105","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1523\/JNEUROSCI.6103-11.2013","article-title":"Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice","volume":"33","author":"Filiano","year":"2013","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01348-6_bib106","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00429-010-0263-z","article-title":"Anterior insula degeneration in frontotemporal dementia","volume":"214","author":"Seeley","year":"2010","journal-title":"Brain Struct Funct"},{"key":"10.1007\/s13311-023-01348-6_bib107","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/gbb.12300","article-title":"Progranulin haploinsufficiency causes biphasic social dominance abnormalities in the tube test","volume":"15","author":"Arrant","year":"2016","journal-title":"Genes Brain Behav"},{"key":"10.1007\/s13311-023-01348-6_bib108","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1126\/science.aak9726","article-title":"History of winning remodels thalamo-PFC circuit to reinforce social dominance","volume":"357","author":"Zhou","year":"2017","journal-title":"Science"},{"key":"10.1007\/s13311-023-01348-6_bib109","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1126\/science.1209951","article-title":"Bidirectional control of social hierarchy by synaptic efficacy in medial prefrontal cortex","volume":"334","author":"Wang","year":"2011","journal-title":"Science"},{"key":"10.1007\/s13311-023-01348-6_bib110","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ana.23722","article-title":"Mouse models of frontotemporal dementia","volume":"72","author":"Roberson","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib111","doi-asserted-by":"crossref","first-page":"16482","DOI":"10.1523\/JNEUROSCI.3418-14.2014","article-title":"Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia","volume":"34","author":"Warmus","year":"2014","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01348-6_bib112","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nm.3717","article-title":"Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia","volume":"20","author":"Gascon","year":"2014","journal-title":"Nat Med"},{"key":"10.1007\/s13311-023-01348-6_bib113","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/brain\/awx060","article-title":"Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia","volume":"140","author":"Arrant","year":"2017","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01348-6_bib114","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5642","article-title":"Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis","volume":"9","author":"Ward","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1007\/s13311-023-01348-6_bib115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2353\/ajpath.2010.090915","article-title":"Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging","volume":"177","author":"Ahmed","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1007\/s13311-023-01348-6_bib116","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-018-0264-6","article-title":"Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency","volume":"13","author":"Arrant","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-023-01348-6_bib117","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1016\/j.cell.2021.08.002","article-title":"Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic","volume":"184","author":"Logan","year":"2021","journal-title":"Cell"},{"key":"10.1007\/s13311-023-01348-6_bib118","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s40478-020-01037-x","article-title":"Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations","volume":"8","author":"Huang","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01348-6_bib119","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13024-018-0281-5","article-title":"Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice","volume":"13","author":"Gotzl","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-023-01348-6_bib120","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1038\/s41467-022-33500-9","article-title":"Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis","volume":"13","author":"Boland","year":"2022","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-023-01348-6_bib121","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40478-014-0078-x","article-title":"Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice","volume":"2","author":"Tanaka","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01348-6_bib122","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2709-7","article-title":"Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency","volume":"588","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01348-6_bib123","doi-asserted-by":"crossref","first-page":"109581","DOI":"10.1016\/j.celrep.2021.109581","article-title":"Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD","volume":"36","author":"Wu","year":"2021","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-023-01348-6_bib124","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1073\/pnas.1700477114","article-title":"Microglial NF\u03baB-TNF\u03b1 hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia","volume":"114","author":"Krabbe","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01348-6_bib125","doi-asserted-by":"crossref","first-page":"101751","DOI":"10.1016\/j.nicl.2019.101751","article-title":"Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers","volume":"22","author":"Lee","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1007\/s13311-023-01348-6_bib126","doi-asserted-by":"crossref","first-page":"E2849","DOI":"10.1073\/pnas.1722344115","article-title":"Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay","volume":"115","author":"Nguyen","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01348-6_bib127","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40478-021-01158-x","article-title":"Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice","volume":"9","author":"Frew","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01348-6_bib128","doi-asserted-by":"crossref","first-page":"16101","DOI":"10.1074\/jbc.M110.193433","article-title":"Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia","volume":"286","author":"Cenik","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-023-01348-6_bib129","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1021\/acschemneuro.9b00281","article-title":"Kinetic tuning of HDAC inhibitors affords potent inducers of progranulin expression","volume":"10","author":"Moreno-Yruela","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1007\/s13311-023-01348-6_bib130","doi-asserted-by":"crossref","first-page":"e2125584","DOI":"10.1001\/jamanetworkopen.2021.25584","article-title":"Effect of the histone deacetylase inhibitor FRM-0334 on progranulin levels in patients with progranulin gene haploinsufficiency: a randomized clinical trial","volume":"4","author":"Ljubenkov","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1007\/s13311-023-01348-6_bib131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-016-0114-3","article-title":"Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia","volume":"11","author":"Holler","year":"2016","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-023-01348-6_bib132","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/10641960802580232","article-title":"Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies","volume":"30","author":"Tomassoni","year":"2008","journal-title":"Clin Exp Hypertens"},{"key":"10.1007\/s13311-023-01348-6_bib133","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.trci.2017.08.002","article-title":"An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations","volume":"3","author":"Sha","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1007\/s13311-023-01348-6_bib134","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.celrep.2012.09.007","article-title":"Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects","volume":"2","author":"Almeida","year":"2012","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-023-01348-6_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.586107","article-title":"Anti-sortilin1 antibody up-regulates progranulin via sortilin1 down-regulation","volume":"14","author":"Miyakawa","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1007\/s13311-023-01348-6_bib136","article-title":"Anti-sortilin antibodies and methods of use thereof","author":"Rosenthal","year":"2018","journal-title":"United States patent US10087255B2"},{"key":"10.1007\/s13311-023-01348-6_bib137","article-title":"AL001 boosts progranulin. Does it slow frontotemporal dementia?","author":"Shugart","year":"2021","journal-title":"AlzForum [Internet]."},{"key":"10.1007\/s13311-023-01348-6_bib138","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40265-017-0711-7","article-title":"Nusinersen: first global approval","volume":"77","author":"Hoy","year":"2017","journal-title":"Drugs"},{"key":"10.1007\/s13311-023-01348-6_bib139","doi-asserted-by":"crossref","first-page":"e10551","DOI":"10.1371\/journal.pone.0010551","article-title":"MicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia","volume":"5","author":"Jiao","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-023-01348-6_bib140","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2353\/ajpath.2010.091202","article-title":"miR-107 regulates granulin\/progranulin with implications for traumatic brain injury and neurodegenerative disease","volume":"177","author":"Wang","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1007\/s13311-023-01348-6_bib141","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1093\/hmg\/ddn257","article-title":"Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia","volume":"17","author":"Rademakers","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-023-01348-6_bib142","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000322538","article-title":"rs5848 variant of progranulin gene is a risk of Alzheimer's disease in the Taiwanese population","volume":"8","author":"Lee","year":"2011","journal-title":"Neurodegener Dis"},{"key":"10.1007\/s13311-023-01348-6_bib143","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.gene.2014.03.041","article-title":"Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease","volume":"542","author":"Sheng","year":"2014","journal-title":"Gene"},{"key":"10.1007\/s13311-023-01348-6_bib144","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3233\/JAD-2009-1170","article-title":"Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease","volume":"18","author":"Fenoglio","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-023-01348-6_bib145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2010.10.009","article-title":"rs5848 polymorphism and serum progranulin level","volume":"300","author":"Hsiung","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-023-01348-6_bib146","doi-asserted-by":"crossref","unstructured":"Aggarwal G, Banerjee S, Jones SA, et al. Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translation. bioRxiv. 2022:2022.01.12.476053.","DOI":"10.1101\/2022.01.12.476053"},{"key":"10.1007\/s13311-023-01348-6_bib147","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13024-020-00369-5","article-title":"Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency","volume":"15","author":"Frew","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-023-01348-6_bib148","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/acn3.51165","article-title":"Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations","volume":"7","author":"Hinderer","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1007\/s13311-023-01348-6_bib149","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1007\/s13311-023-01348-6_bib150","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ymthe.2018.11.013","article-title":"AAV-mediated progranulin delivery to a mouse model of progranulin deficiency causes T cell-mediated toxicity","volume":"27","author":"Amado","year":"2019","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-023-01348-6_bib151","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/s41591-022-01942-9","article-title":"Temporal order of clinical and biomarker changes in familial frontotemporal dementia","volume":"28","author":"Staffaroni","year":"2022","journal-title":"Nat Med"},{"key":"10.1007\/s13311-023-01348-6_bib152","doi-asserted-by":"crossref","first-page":"e109108","DOI":"10.15252\/embj.2021109108","article-title":"Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency","volume":"41","author":"Reifschneider","year":"2022","journal-title":"EMBO J"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01348-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01348-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01348-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:32:58Z","timestamp":1761805978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923001113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":152,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1878747923001113"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01348-6","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01348-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The Author(s). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}